Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial [JAMA Neurol Aug 2020]
Posted byTerri Fettinger
This is a widget ready area. Add some and they will appear here.
